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Agonist-stimulated contraction of smooth muscle, including
that of the uterus, involves the integration of many signal
transducing events linking receptor occupation at the plasma
membrane with varied intracellular effectors and eventual
alteration of the activation state of the myofilaments in the
cell cytoplasm. Precise co-ordination of these myometrial
signalling events at term is paramount to ensuring efficient
and powerful contractile activity necessary for expeditious
expulsion of the fetus. A comprehension of the complex
intracellular mechanisms of action of uterotonic agents is thus
essential not only to our understanding of parturition but also
for the management of situations involving dysfunctional
uterine performance including, for example, those associated
with pre-term labour, non-labouring uteri and post-partum
haemorrhage. As such, in this paper we review recent studies
that shed light on many of the mechanisms contributing to the
efficient coupling of extracellular contractile stimuli and
intracellular effectors in uterine smooth muscle. Special
consideration is given to the processes of receptor-coupled
recruitment to the plasma membrane of intracellular proteins
important for agonist-induced alterations in Ca2+ sensitivity
of contraction such as rhoA and ROK (rho-associated
kinase); evidence for the involvement of caveolins, proteins
integral to plasma membranous caveolae, in this signal
transduction cascade is discussed. 
Receptor activation of uterine smooth muscle
Agonist-stimulation of uterine smooth muscle primarily
involves an elevation of intracellular Ca2+ ([Ca2+]i) via
increased trans-sarcolemmal influx and/or release of Ca2+
from intracellular stores especially those responsive to
generation of IP3 (inositol 1,4,5-trisphosphate; Taggart &
Wray, 1998). The elevation in [Ca2+]i results in activation
of the Ca2+- and calmodulin-dependent enzyme myosin
light chain kinase and subsequent phosphorylation of the
regulatory myosin light chains (MLC20; Word et al. 1991;
Taggart et al. 1997). This increased phosphorylation of
MLC20 allows for enhanced actomyosin Mg-ATPase
activity and subsequent contractility. Smooth muscle
relaxation is preceded by dephosphorylation of MLC20 by
a myosin phosphatase (MLCP; Khromov et al. 1995)
which has been cloned from uterine tissue (Johnson et al.
1997). However, a prominent additional mechanism
whereby agonists can stimulate smooth muscle
contractility is by sensitising the myofilaments to the
activating [Ca2+]i. This occurs in both intact (Taggart &
Wray, 1998) and permeabilised (Izumi et al. 1996; Somlyo
& Somlyo, 1998; Taggart et al. 1999) uterine smooth
muscle and, in other smooth muscles, has been associated
with corresponding elevations of MLC20 phosphorylation
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(Kitizawa et al. 1991; Fu et al. 1998; Swärd et al. 2000).
This agonist-induced Ca2+ sensitisation of MLC20
phosphorylation and force is thought to result from
inhibition of MLCP (Kureishi et al. 1996; Swärd et al.
2000) although an involvement of thin filament-linked
regulation has also been suggested for other smooth
muscles (Horowitz et al. 1996). 
Agonist Ca2+ sensitisation of single uterine smooth muscle
cell force production
As first reported by Taggart et al. (1999), and illustrated
in Fig. 1, the contractile force of permeabilised single
isolated uterine smooth muscle cells from pregnant rat can
be monitored in response to agonist application. Brief
permeabilisation of these cells with saponin allows the
concentration of activating Ca2+ surrounding the myo-
filaments to be strictly controlled by that in the bathing
milieu. At suprabasal, but sub-maximal activating Ca2+
(pCa 6.7; Crichton et al. 1993) application of the
muscarinic agonist carbachol results in pronounced
contraction of these single uterine cells. Carbachol
application resulted in contractions of magnitude
4.30 ± 0.30 µN  (n = 5) similar to that reported previously
for uterine smooth muscle (Taggart et al. 1999) but
significantly greater than that observed for agonist
stimulation of isolated vascular smooth muscle cells
(Collins et al. 1992; Lee et al. 1999). Wortmannin, an
inhibitor of myosin light chain kinase (MLCK),
completely reversed carbachol-induced Ca2+ sensitisation
(n = 5) – and even slightly decreased the basal force in pCa
6.7 (Fig. 1) – indicating an important role of an active
MLCK to the sensitisation process. It is to be noted,
however, that wortmannin is also capable of inhibiting
several other kinases (Linseman et al. 1999; Duan et al.
2000).
One molecule suggested to be important for agonist-induced
Ca2+ sensitisation is the small G-protein rhoA which acts
downstream of receptor occupancy. Inactivation of rhoA in a
variety of smooth muscles by ADP-ribosylation (Otto et al.
1996; Fujihara et al. 1997) or monoglucosylation (Otto et al.
1996; Lucius et al. 1998) results in inhibition of Ca2+
sensitisation. The Ca2+-sensitising effects of rhoA activation
appear mediated, in part at least, by its effector molecule
ROK. As shown in Fig. 1, pharmacological inhibition of
ROK with Y-27632 (Ueheta et al. 1997) results in 91 ± 5.6%
(n = 4) reduction of carbachol-induced Ca2+ sensitisation of
single uterine smooth muscle cell force. This is in agreement
with the abrogation of oxytocin-induced Ca2+ sensitisation in
multicellular preparations (Somlyo & Somlyo, 1998)
indicating that multiple uterotonic agents may sensitise the
myofilaments to Ca2+ via a rhoA/ROK-mediated reduction
of MLCP activity. Notably, uterine ROK expression is
increased with pregnancy (Niiro et al. 1997; Moore et al.
2000) as is agonist-induced Ca2+ sensitisation of force
(Taggart & Wray, 1998). However, the assumed inhibition of
MLCP activity in uterine single smooth muscle cells by
activation of ROK, at least in response to muscarinic
activation, is unlikely to be complete as application of the
phosphatase inhibitor microcystin increases Ca2+ sensitisation
to carbachol by a further 60.5 ± 12.4%  (n = 3; see Fig. 1).
Additionally, in light of these results and also the rather steep
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Figure 1
Agonist-induced Ca2+ sensitisation of single uterine smooth muscle cell force production. Single uterine
smooth muscle cells were enzymatically isolated from 19-day pregnant rat, briefly permeabilised with
saponin and prepared for measurement of force as described by Taggart et al. (1999). Permeabilised cells
incubated in pCa 6.7 solution exhibited prominent agonist-induced Ca2+ sensitisation by contracting
strongly to 100 µM carbachol (CCh). A, enhancement of CCh-induced Ca2+-sensitised contractions by
the phosphatase inhibitor microcystin-LR. B, inhibition of agonist-induced contractions by MLCK
inhibitor wortmannin. C, reduction of CCh-induced contractions by ROK inhibitor Y-27632.) at Sud Mooon University on August 4, 2014ep.physoc.orgDownloaded from Exp Physiol (
relationship reported between agonist Ca2+ sensitisation of
MLC20 phosphorylation and force in smooth muscle (Buus et
al. 1998; Swärd et al. 2000), alternative possible pathways of
rhoA/ROK-mediated Ca2+ sensitisation, such as alteration of
actin filament dynamic equilibrium (Mehta & Gunst, 1999),
require fuller investigation. For example, treatment with
cytochalasin D, an inhibitor of F-/G-actin dynamic
equilibrium, results in attenuation of intact uterine smooth
muscle contractions in response to carbachol without altering
[Ca2+]i responsiveness (Taggart et al. 2001).
Agonist-stimulated cellular redistribution of rhoA and
ROK
In resting uterine cells rhoA is diffusely distributed
throughout the cytoplasm (Yu & López Bernal, 1998;
Taggart et al. 1999) most probably existing in a rhoA–GDI
(guanine nucleotide dissociation inhibitor) complex.
Muscarinic stimulation of isolated uterine smooth muscle
cells results in the translocation of rhoA from the cytoplasm
to the cell periphery (Taggart et al. 1999). Membranous
relocation of rhoA is essential for its Ca2+-sensitising actions
in a variety of smooth muscles (Gong et al. 1996; Fujihara et
al. 1997). Notably, ROKa is similarly redistributed from the
cytoplasm to the plasma membrane of intact uterine smooth
muscle cells following identical conditions of receptor
activation that result in maintained Ca2+-sensitised
contractions of permeabilised cells (Taggart et al. 1999). Ca2+
sensitisation thus occurs without significant relocalisation of
ROK away from submembranous regions of the cell. The
precise subcellular distribution of the trimeric MLCP, or the
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Figure 2
Caveolin and rhoA localisation in uterine smooth muscle. Laser scanning confocal microscopy of single
uterine smooth muscle cells isolated from pregnant rat was used to establish the localisations of
caveolins and rhoA. Central cell sections are illustrated. A, caveolin-1, -2 and -3 all exhibit a
predominantly plasma membranous distribution in single myometrial cells. B, RhoA localisation before
and after cellular introduction of the fluorescein isothiocyanate (FITC)-labelled (green) caveolin-1
scaffolding domain peptide. RhoA shows a stimulus-dependent relocalisation from the cytosol to the
cell periphery in control cells. RhoA transocation is inhibited by the caveolin-1 scaffolding domain
peptide. Scale bars represent 10 µm. Adapted from Taggart et al. (2000b).) at Sud Mooon University on August 4, 2014ep.physoc.orgDownloaded from Exp Physiol (
targetting subunit of MLCP (MYPT) that is a major
substrate for ROK, is unknown in smooth muscle. Although
most MLCP activity is found in myofibrillar cell fractions
(Alessi et al. 1992) substantial MYPT is present in membrane
fractions (Kimura et al. 1996; Ito et al. 1997), has been shown
to be regulated by interactions with acidic phospholipids (Ito
et al. 1997) and, in confluent cultured cells, has been localised
close to the plasma membrane (Hirano et al. 1999). On
balance, it would appear, therefore, that the major subcellular
site(s) of rhoA/ROK-mediated Ca2+ sensitisation in uterine
smooth muscle lies in close proximity to the plasma
membrane. Indeed, the ultrastructural arrangement of the
smooth muscle cell – where contractile and cytoskeletal
filaments exit membrane attachment sites at an acute angle to
the cell axis – is consistent with a significant proportion of
contractile load being sensed by the plasma membrane (Small
& Gimona, 1998). In this manner it may be feasible for the
effects of discrete changes in the activation state of
myofilaments close to the plasma membrane to be transduced
across the whole cell. 
What might be the nature of the membrane structure(s) that
co-ordinates the recruitment of downstream signalling
molecules such as rhoA and ROK? Electron micrography of
uterine smooth muscle illustrates that the membrane consists
of periodic electron dense material – the dense plaques where
actin filaments insert into the membrane – interspersed with
rows of Ω-shaped invaginations known as caveolae (Taggart
et al. 2000b). Caveolins are a family of proteins – three main
mammalian isoforms exist (termed caveolin-1, -2 and -3) –
critical to caveolar formation that, in vitro, interact with a
variety of signal transducing molecules (reviewed by
Okamoto et al. 1998 and Shaul & Anderson, 1998). A short
cytoplasmic region of caveolin appears essential for the
interaction with signal transduction molecules and has thus
been termed the scaffolding domain. The possibility exists,
therefore, that caveolae, as a result of the properties of
caveolins, may be specialised plasmalemmal regions involved
in the co-ordination of receptor-coupled signalling events.
Caveolins and uterine smooth muscle signal transduction
Use of isoform-specific antibodies indicates that each caveolin
isoform is expressed in rat and human uterine smooth muscle
irrespective of gestational status (Taggart et al. 2000a,b).
Laser scanning confocal microscopy of single isolated rat
uterine smooth muscle cells indicates that caveolins-1, -2 and
-3 are all localised predominantly at the plasma membrane
(Fig. 2). Increased intensity of staining is often observed at the
cell extremities and membranous areas closely apposing the
nucleus (Taggart et al. 2000b). Thus caveolin localisation is
suitable for any potential interaction with signalling
molecules redistributed to the plasma membrane following
cell stimulation.
Introduction to single isolated uterine smooth muscle cells of
the caveolin-1 scaffolding domain peptide completely
inhibited rhoA translocation following muscarinic
stimulation (Fig. 3). PKCa, suggested to be important in
agonist-induced Ca2+ sensitisation of other smooth muscles
(Lee et al. 1999), also shows a receptor-coupled relocalisation
to the plasma membrane of uterine smooth muscle cells
(Taggart et al. 1999) that is inhibited by the caveolin-1
scaffolding domain peptide (Taggart et al. 2000b).
Translocation was unaffected in sham-treated cells, or in cells
treated with a scrambled version of the caveolin scaffolding
domain peptide (Taggart et al. 2000b). These data suggest
that both rhoA and PKCa interact with caveolins via the
N-terminal proximal scaffolding domain in intact uterine
smooth muscle, results consistent with in vitro biochemical
studies (Oka et al. 1997; Gingras et al. 1998). Furthermore,
Couet et al. (1997) described caveolin binding motifs typical
of many signalling molecules found to interact with caveolin
and both PKCa and rhoA contain corresponding sequences.
In particular, the sites of monoglucosylation (T37) and ADP-
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Figure 3
Inhibition of uterine smooth muscle contraction by caveolin-1 scaffolding domain. The FITC-labelled
caveolin-1 scaffolding domain peptide was chemically loaded into intact uterine smooth muscle strips by
a procedure similar to that described by Taggart et al. (2000b). Contractions to CCh (100 µM) in 0 Ca2+
solution were dose-dependently inhibited by the scaffolding domain (A) in parallel with increased
fluorescent labelling of the tissues (B). Contractions were unaffected in sham-treated tissues.) at Sud Mooon University on August 4, 2014ep.physoc.orgDownloaded from Exp Physiol (
ribosylation (N41) on rhoA are both contained within the
putative caveolin binding motif (34YVPTVFENY41); this
motif also overlaps with a region important for determining
rhoA binding with ROK (Fujisawa et al. 1998). It is presently
unknown if caveolin directly interacts with ROK but it too
contains putative caveolin binding motifs in the catalytic
domain of the molecule (151WVVQLFCAF159 and
164YLYMVMEY171). Collectively, these data suggest that
caveolin interacts with, and regulates activity of, rhoA (and
possibly ROK). Consistent with such a mechanism of action
is the observation that introduction of the caveolin-1
scaffolding domain peptide to intact uterine smooth muscle
resulted in inhibition of contractile function: contractions in
response to carbachol (but not those in response to KCl) were
significantly reduced whilst responses in sham-treated tissues
remained unaltered (Fig. 3). 
Conclusions
Receptor-stimulated membranous recruitment of key
signalling molecules rhoA and ROK appears to be crucial for
agonist-induced Ca2+ sensitisation in single uterine smooth
muscle cells. Caveolae, as a result of the regulatory actions of
caveolins, are suggested to be specialised plasmalemmal
regions involved in this integration of extracellular signals and
intracellular effectors. Such discrete membranous localisation
of signal transducing events is likely to contribute to the
efficacy of receptor-coupled contractile activation of uterine
smooth muscle. 
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